Jan-Michael Peters | |
|---|---|
| Born | 16 August 1962 Schleswig-Holstein, Germany |
| Citizenship | German |
| Education |
|
| Awards |
|
| Scientific career | |
| Fields | cell biology, molecular biology |
| Workplaces | |
| Thesis | Strukturelle und molekularbiologische Untersuchung eines ubiquitären 15S-Mg2+-ATPase-Komplexes (1991) |
| Werner Franke | |
Jan-Michael Peters (born 16 August 1962) is a German cell and molecular biologist whose research focuses on genome organisation and chromosome segregation. He has been scientific director of the Research Institute of Molecular Pathology (IMP) in Vienna since 2013.
Peters was born and grew up in Schleswig-Holstein. He has described an interest in biology dating back to his childhood.
Peters began studying biology at the University of Kiel in 1982, where he received his pre-diploma. In 1988, he completed his diploma studies at the University of Heidelberg, where he also obtained his PhD in cell biology in 1991. His doctoral supervisor was Werner Franke. His doctoral research included the identification and characterisation of p97 ATPase and its relationship to other members of the enzyme family now known as AAA ATPases, as well as the purification and characterisation of the 26S proteasome.
Between 1992 and 1993, Peters worked as a postdoctoral fellow with Franke at the German Cancer Research Center (DKFZ) in Heidelberg, continuing his research on p97 ATPase and the 26S proteasome. His work showed that 26S proteasomes are present in both the cytoplasm and the cell nucleus. He also proposed that their 19S regulatory complexes use ATP hydrolysis to bind and unfold protein substrates and transport them into the proteolytic 20S core.
In 1994, Peters joined the laboratory of Marc W. Kirschner at Harvard Medical School in Boston as a postdoctoral fellow, where he contributed to the discovery of the anaphase-promoting complex/cyclosome (APC/C), which regulates chromosome segregation.
Peters joined the IMP in 1996 as a junior group leader and became a senior scientist in 2002. He was appointed scientific deputy director in 2011 and scientific director in 2013, succeeding Barry Dickson.
Peters's research group studies the molecular mechanisms of chromosome organisation, chromosome segregation and cell division. His work has examined the regulation and mechanisms of proteins involved in chromosome segregation during mitosis, including APC/C and polo-like kinase 1 (PLK1). He also contributed to research on PLK1 inhibition as a potential approach to cancer treatment, including a study showing that the inhibitor BI 2536 inhibited tumour growth in preclinical models.
Peters and his colleagues contributed to establishing how cohesin organises genomic DNA through loop extrusion. Their research showed that topologically associating domains and chromatin loops depend on cohesin, and that cohesin-associated proteins, including WAPL, CTCF and PDS5 proteins, regulate the organisation of these structures. WAPL limits the length and lifetime of loops by promoting cohesin release from chromatin, while CTCF helps determine their genomic positions.
In 2019, his group used biochemical reconstitution and single-molecule imaging to demonstrate that human cohesin, together with NIPBL–MAU2, acts as an ATP-dependent motor protein that extrudes DNA into loops.
His group has also investigated the consequences of mutations affecting cohesin and its regulators. A 2022 study showed that several NIPBL mutations associated with Cornelia de Lange syndrome impair cohesin-mediated DNA loop extrusion, suggesting that defects in this process may contribute to the disorder. His laboratory also studies how cohesin mutations affect genome architecture in cancer.
Peters coordinated EuroDYNA, a European Science Foundation research programme, between 2005 and 2008. Research associated with the programme included work on the relationship between cohesin and CTCF in gene regulation. Peters and his colleagues showed that cohesin contributes to CTCF-mediated transcriptional insulation.
Between 2004 and 2009, Peters coordinated the European Union-funded MitoCheck project, which aimed to identify genes involved in mitosis. Between 2010 and 2015, he headed its successor, MitoSys, an interdisciplinary project investigating how genes and proteins orchestrate mitosis in human cells. MitoSys was accompanied by Lens on Life, an art project and exhibition exploring cell division through collaborations between artists and scientists.